These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

852 related items for PubMed ID: 34464510

  • 1. Relationship of established risk factors with breast cancer subtypes.
    McCarthy AM, Friebel-Klingner T, Ehsan S, He W, Welch M, Chen J, Kontos D, Domchek SM, Conant EF, Semine A, Hughes K, Bardia A, Lehman C, Armstrong K.
    Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
    [Abstract] [Full Text] [Related]

  • 2. Feasibility of risk assessment for breast cancer molecular subtypes.
    McCarthy AM, Ehsan S, Hughes KS, Lehman CD, Conant EF, Kontos D, Armstrong K, Chen J.
    Breast Cancer Res Treat; 2024 Nov; 208(1):103-110. PubMed ID: 38916820
    [Abstract] [Full Text] [Related]

  • 3. A Pooled Case-only Analysis of Reproductive Risk Factors and Breast Cancer Subtype Among Black Women in the Southeastern United States.
    Sanderson M, Pal T, Beeghly-Fadiel A, Fadden MK, Dujon SA, Clinton C, Jimenez C, Davis J, Fortune M, Thompson J, Benson K, Conley N, Reid S, Tezak A, Shu XO, Zheng W, Blot WJ, Lipworth L.
    Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1416-1423. PubMed ID: 33947654
    [Abstract] [Full Text] [Related]

  • 4. Association of breast cancer subtypes and body mass index.
    Petekkaya I, Sahin U, Gezgen G, Solak M, Yuce D, Dizdar O, Arslan C, Ayyildiz V, Altundag K.
    Tumori; 2013 Jul; 99(2):129-33. PubMed ID: 23748802
    [Abstract] [Full Text] [Related]

  • 5. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
    Cherbal F, Gaceb H, Mehemmai C, Saiah I, Bakour R, Rouis AO, Boualga K, Benbrahim W, Mahfouf H.
    Breast Dis; 2015 Jul; 35(2):95-102. PubMed ID: 25736840
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
    Parise CA, Bauer KR, Brown MM, Caggiano V.
    Breast J; 2009 Jul; 15(6):593-602. PubMed ID: 19764994
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis.
    Ma H, Ursin G, Xu X, Lee E, Togawa K, Malone KE, Marchbanks PA, McDonald JA, Simon MS, Folger SG, Lu Y, Sullivan-Halley J, Deapen DM, Press MF, Bernstein L.
    Breast Cancer Res; 2018 Jan 22; 20(1):5. PubMed ID: 29357906
    [Abstract] [Full Text] [Related]

  • 11. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
    Johansson ALV, Trewin CB, Hjerkind KV, Ellingjord-Dale M, Johannesen TB, Ursin G.
    Int J Cancer; 2019 Mar 15; 144(6):1251-1261. PubMed ID: 30367449
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
    Ellingjord-Dale M, Vos L, Tretli S, Hofvind S, Dos-Santos-Silva I, Ursin G.
    Breast Cancer Res; 2017 Jan 23; 19(1):10. PubMed ID: 28114999
    [Abstract] [Full Text] [Related]

  • 14. Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.
    Chen XS, Ma CD, Wu JY, Yang WT, Lu HF, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW.
    Tumori; 2010 Jan 23; 96(1):103-10. PubMed ID: 20437866
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10-year retrospective multi-center study in China.
    Song Q, Huang R, Li J, Fan J, Zheng S, Zhang B, Yang H, Tang Z, He J, Xie X, Li H, Li J, Qiao Y.
    PLoS One; 2013 Jan 23; 8(8):e72175. PubMed ID: 23977244
    [Abstract] [Full Text] [Related]

  • 18. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.
    Chen L, Cook LS, Tang MT, Porter PL, Hill DA, Wiggins CL, Li CI.
    Breast Cancer Res Treat; 2016 Jun 23; 157(3):545-54. PubMed ID: 27220749
    [Abstract] [Full Text] [Related]

  • 19. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer.
    Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O'Meara ES, Li CI.
    Ann Epidemiol; 2012 May 23; 22(5):340-8. PubMed ID: 22366170
    [Abstract] [Full Text] [Related]

  • 20. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
    Ihemelandu CU, Leffall LD, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.
    J Surg Res; 2007 Nov 23; 143(1):109-18. PubMed ID: 17950079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.